February 21, 2017 – (PHILADELPHIA) –Shaw of Massachusetts General Hospital Cancer Center (MGHCC) and Jänne Join Wolchok of Dana-Farber Cancer Institute (DFCI) have been named co-leaders of the Stand Up To Cancer-American Cancer Society Lung Cancer Dream Team.
SU2C Opens Calls for New Approach to “Intercept” Cancer in Dream Teams for Pancreas and Lung CancersJanuary 26, 2016 – (PHILADELPHIA) – Stand Up To Cancer Ushers In New Approach to Research with Calls by AACR for SU2C Dream Teams on “Interception” of Pancreas and Lung Cancers, Each Funded at $7 Million With Support from the Lustgarten Foundation for Pancreatic Research, LUNGevity Foundation, and the American Lung Association’s LUNG FORCE
December 8, 2016 – (LOS ANGELES / NEW YORK) – Be The Breakthrough™ Celebrates Progress Against Cancer and Calls on Everyone to Play a Role in Fight Against Disease
November 10, 2016 - Stand Up To Cancer (SU2C) is making $7.5 million in research grants available to early-career scientists who are pursuing innovative cancer research projects focusing on immuno-oncology, the American Association for Cancer Research (AACR) announced today.
November 3, 2016 - Stand Up To Cancer (SU2C) announced today an SU2C Catalyst™ collaboration with Genentech, a member of the Roche Group, that will help accelerate the development of new cancer treatments and combination therapies by giving awardees funding and access to a dozen of the company’s medicines.